Abstract
Objectives
To identify current and potential roles for, and systematic barriers encountered by, local health departments (LHDs) engaging in PrEP implementation.
Methods Web-based assessment created with Qualtrics® from Oct.-Dec. 2020 distributed via e-mail to 1,096 LHDs that indicated they provided HIV or STD screening and/or treatment in NACCHO’s 2019 National Profile of Local Health Departments.
Results Of 354 respondents, 46% of LHDs were engaged in PrEP implementation compared with 29% in 2015. Activities included: referring to PrEP providers (68%); conducting consumer education (65%); promoting PrEP (59%); educating providers; (48%); and prescribing PrEP (42%). The top challenges to initiating or expanding PrEP implementation were lack of funding and staff, and 41% described staff reductions during COVID-19.
Conclusions LHD engagement in PrEP implementation has increased significantly since 2015 but many LHDs still encounter barriers to initiating or expanding PrEP activities.
Policy Implications Robust funding of public health infrastructure can ensure that LHDs and their partners are equipped to provide PrEP access for all who may benefit from it during future public health emergencies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was reviewed by the CDC OMB-PRA under the CSTLTS Generic which allows for data collection from state and local governmental agency staff tasked with the provision of essential public health services. The review body determined the paper not to be human subjects research.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclaimer: The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention
Data Availability
All relevant data are within the manuscript and its Supporting Information files. Supplemental data will be made available through NACCHO.org, CDC.gov, and/or OpenICPSR upon acceptance for publication.
